Use access key #2 to skip to page content.

IBDvalueinvestin (99.64)

Celldex has potential to have a blockbuster Breast Cancer Drug

Recs

4

January 31, 2012 – Comments (1) | RELATED TICKERS: CLDX , VRTX , IDIX

Results from a Phase II study for CDX-011 - breast cancer are due for release before the summer. The company also is conducting  Phase III and Phase II trial for its Rindopepimut in the treatment of glioblastoma.

 

2012 has started out with a bang for the biotechs and show no end in sight with so many pending FDA approvals coming in next couple of months. Today we got another FDA approval for VRTX.

1 Comments – Post Your Own

#1) On January 31, 2012 at 1:14 PM, IBDvalueinvestin (99.64) wrote:

CLDX is almost to the promise land:

Here is link to Phase III drug for CLDX

 http://ir.celldextherapeutics.com/phoenix.zhtml?c=93243&p=irol-newsArticle&ID=1635138&highlight=

Report this comment

Featured Broker Partners


Advertisement